We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Repurposing Anti-rejection Drug to Treat Liver Cancer

News   Feb 01, 2019 | Original story from University of Pittsburgh

 
Repurposing Anti-rejection Drug to Treat Liver Cancer

These are mouse liver tissues showing cells surrounding the central vein with active mTOR (red) and glutamine synthetase (green) being present in the same cells (yellow). Credit: Cell Reports/University of Pittsburgh

 
 
 

RELATED ARTICLES

Metabolic Dysfunction Could Be a Potential Therapy for Alzheimer’s Disease

News

A team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.

READ MORE

Museums Are Putting Ancient DNA To Work for Wildlife

News

The museum-based lab is working with researchers and government agencies on projects that require DNA analysis, such as wildlife conservation.

READ MORE

It Is Possible to Extend Life Without Any Genetic Modification, Study Suggests

News

Given the relationship between telomeres and ageing - telomeres shorten throughout life, so older organisms have shorter telomeres -, scientists launched a study generating mice in which 100% of their cells had hyper-long telomeres.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE